InvestorsHub Logo
icon url

dr_lowenstein

11/18/22 1:47 PM

#535163 RE: SkyLimit2022 #535153

yes some patients would want to try it, but one of the issues they acknowledged in the trial was slow recruitment, so WHY, was there not an onslaught of study participants

second I suggest reviewing previous ODAC meetings, Period